Government
PRODUCTS
-
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.
-
As the final step before treated wastewater leaves the plant, effective disinfection is extremely important to protect human health, and the maintenance of the environment. This process eliminates pathogenic organisms that cannot be removed by previous treatment steps and reduces the spread of pathogens in the natural ecosystem.
USP’s current offerings include our unrivaled in-house CFD modeling expertise that can be used to optimize the injection, mixing and feed rates of PAA to meet the disinfection requirements of a facility. Also, launching later this year, is our OaSys iCT™ is a novel control approach that optimizes disinfection performance by calculating the optimal chemical dosage that accounts for sources of treatment variability in real time. Available for use with PAA or chlorine.
-
Preclinical immunotoxicology studies play a crucial role in assessing the potential adverse effects of drugs, chemicals, or other substances on the immune system before they advance to first-in-human linical trials.
-
Designing a high-performance, energy-efficient antenna array for 5G or SATCOM applications is no small feat. It requires deep expertise, precise calculations, and the ability to balance a wide range of system-level trade-offs.
-
Schneider-Kreuznach provides durable, high-performance optical solutions for security and defense, featuring advanced stabilization, motorized options, rigorous quality standards, and ITAR certification for reliable performance in demanding environments.
WHITE PAPERS AND CASE STUDIES
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Clinical Trial Starts Rose At Slower Pace In 2024
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
How To Successfully Scale QC For Rapid Growth
Learn how one CDMO successfully streamlined and modernized its QC workflows and processes to address challenges related to the increasing demand for cell and gene therapy manufacturing services.
-
Single-Use Assembly Capabilities To Keep Pace With Biopharma Dynamics
Discover how a vendor-independent partner assists global life science companies and CDMOs with innovative single-use technologies to mitigate risks and ensure uninterrupted manufacturing.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
Blending Tradition And Technology For A Water-Resilient Future
Discover how a desert utility is evolving its operations to safeguard Tucson’s water supply for generations to come.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
Putting The Squeeze In Sponge Cities: Amsterdam's Waternet And The Innovative RESILIO Blue-Green Roof Project
The RESILIO project has helped Amsterdam repurpose rooftops as smart blue-green roofs to reuse rainwater and prevent localized flooding. This project, along with other sustainable water initiatives like the Amsterdam Rainproof program, continues to position the Netherlands at the forefront of water management.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
Municipal Effluent Treatment In India
Discover how an agency balanced effective disinfection while minimizing environmental impact and ensuring the safety of both the public and workers in its wastewater treatment practices.
-
Operationalizing Disclosure Intelligence For Compliance At Scale
Learn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.
-
Guide To Navigating The Complex And Expanding Regulatory Landscape
In today’s complex landscape, organizations face growing compliance demands from diverse sources. Learn how a strong compliance system and culture of accountability drive sustainable growth and protect long-term success.
NEWS
-
June Jobs Report: Energy Services Sector Navigates Economic Headwinds With Continued Focus On Stability7/3/2025
Today, the Energy Workforce & Technology Council (EWTC) released its June 2025 jobs report, reflecting a modest dip in employment within the energy services sector amid continued economic uncertainty.
-
Projectmates Awarded Five-Year GSA Schedule Extension1/16/2025
Projectmates, the award-winning construction program management software, is proud to announce a five-year extension of its GSA Schedule contract.
-
CAI And Sourcewell Drive Negotiating Power And Cost Savings For Public Sector Procurement Processes11/18/2025
CAI, a global services firm, announced today a partnership with Sourcewell, a government agency offering cooperative purchasing and procurement solutions to more than 50,000 participating government, education and nonprofit organizations across the United States and Canada.
-
Tata Power And Druk Green Power Corporation Limited (DGPC) Sign Commercial Agreements For The Implementation Of 1,125 MW Dorjilung Hydroelectric Power Project In Bhutan11/21/2025
The Tata Power Company Limited (Tata Power), one of India’s largest integrated power companies, today announced the signing of Commercial Agreements with Druk Green Power Corporation Limited (DGPC) for the implementation of the 1,125 MW Dorjilung project.
-
Lunai Bioworks Inc. Unveils Transformer Platform To Secure Generative AI And Accelerate Drug Discovery9/9/2025
Lunai Bioworks Inc., an AI-powered drug discovery and biodefense company, today announced the launch of a transformer-based platform that embeds biological risk intelligence directly into large language model (LLM) pipelines.